adenosine and su 11248
adenosine has been researched along with su 11248 in 5 studies
Research
Studies (5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bekerman, E; Einav, S | 1 |
| Cooper, S; Hussain, A; Maddock, H; Mee, C; Sandhu, H | 1 |
| Chen, Y; Ding, L; Huan, W; Li, G; Li, Y; Lu, Z; Luo, W; Ni, K; Qi, C; Qian, J; Ren, L; Shen, D; Wang, M; Wang, R; Xia, L; Xie, H; Xue, D; Yu, C | 1 |
| Liu, J; Lv, Z; Wang, J; Zhang, L; Zhang, Y | 1 |
Reviews
1 review(s) available for adenosine and su 11248
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Other Studies
4 other study(ies) available for adenosine and su 11248
| Article | Year |
|---|---|
Infectious disease. Combating emerging viral threats.
Topics: Adenine; Adenosine; Antiviral Agents; Benzamides; Chloroquine; Communicable Diseases, Emerging; Cyclosporins; Cytosine; Dengue; Drug Approval; Drug Design; Erlotinib Hydrochloride; Hemorrhagic Fever, Ebola; Humans; Imatinib Mesylate; Indoles; Organophosphonates; Piperazines; Purine Nucleosides; Pyrimidines; Pyrroles; Pyrrolidines; Quinazolines; Sunitinib; Viruses | 2015 |
Attenuation of Sunitinib-induced cardiotoxicity through the A3 adenosine receptor activation.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Cell Survival; Heart; Heart Rate; Hemodynamics; HL-60 Cells; Humans; Indoles; MicroRNAs; Protein Kinase C-alpha; Pyrroles; Receptor, Adenosine A3; Signal Transduction; Sunitinib; Ventricular Function, Left | 2017 |
N
Topics: Adenosine; Angiogenesis Inhibitors; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Humans; Kidney Neoplasms; Male; Methyltransferases; Neovascularization, Pathologic; Sunitinib; TNF Receptor-Associated Factor 1 | 2022 |
N6-methyladenosine long non-coding RNAs reveal novel tool to implicate overall survival and immune microenvironment in renal clear cell carcinoma.
Topics: Adenosine; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; RNA, Long Noncoding; Sunitinib; Tumor Microenvironment | 2023 |